Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
letter
. 1995 Dec;57(6):1508–1510.

Pyridinium cross-links in heritable disorders of collagen.

N Pasquali, M J Still, P P Dembure, L J Elsas
PMCID: PMC1801431  PMID: 8533784

Full text

PDF
1508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beardsworth L. J., Eyre D. R., Dickson I. R. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res. 1990 Jul;5(7):671–676. doi: 10.1002/jbmr.5650050702. [DOI] [PubMed] [Google Scholar]
  2. Coleman R. E., Houston S., James I., Rodger A., Rubens R. D., Leonard R. C., Ford J. Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer. 1992 May;65(5):766–768. doi: 10.1038/bjc.1992.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dembure P. P., Janko A. R., Priest J. H., Elsas L. J. Ascorbate regulation of collagen biosynthesis in Ehlers-Danlos syndrome, type VI. Metabolism. 1987 Jul;36(7):687–691. doi: 10.1016/0026-0495(87)90155-7. [DOI] [PubMed] [Google Scholar]
  4. Dembure P. P., Priest J. H., Snoddy S. C., Elsas L. J. Genotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers-Danlos syndrome type VI. Am J Hum Genet. 1984 Jul;36(4):783–790. [PMC free article] [PubMed] [Google Scholar]
  5. Elsas L. J., 2nd, Miller R. L., Pinnell S. R. Inherited human collagen lysyl hydroxylase deficiency: ascorbic acid response. J Pediatr. 1978 Mar;92(3):378–384. doi: 10.1016/s0022-3476(78)80423-5. [DOI] [PubMed] [Google Scholar]
  6. Eyre D. R., Glimcher M. J. Reducible crosslinks in hydroxylysine-deficient collagens of a heritable disorder of connective tissue. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2594–2598. doi: 10.1073/pnas.69.9.2594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eyre D. R., Koob T. J., Van Ness K. P. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem. 1984 Mar;137(2):380–388. doi: 10.1016/0003-2697(84)90101-5. [DOI] [PubMed] [Google Scholar]
  8. Eyre D. R., Paz M. A., Gallop P. M. Cross-linking in collagen and elastin. Annu Rev Biochem. 1984;53:717–748. doi: 10.1146/annurev.bi.53.070184.003441. [DOI] [PubMed] [Google Scholar]
  9. Gay B. B., Jr, Elsas L. J., Wyly J. B., Pasquali M. Osteopathia striata with cranial sclerosis. Pediatr Radiol. 1994;24(1):56–60. doi: 10.1007/BF02017665. [DOI] [PubMed] [Google Scholar]
  10. Ha V. T., Marshall M. K., Elsas L. J., Pinnell S. R., Yeowell H. N. A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. J Clin Invest. 1994 Apr;93(4):1716–1721. doi: 10.1172/JCI117155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hautala T., Heikkinen J., Kivirikko K. I., Myllylä R. A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers-Danlos syndrome in two siblings. Genomics. 1993 Feb;15(2):399–404. doi: 10.1006/geno.1993.1074. [DOI] [PubMed] [Google Scholar]
  12. Krane S. M., Pinnell S. R., Erbe R. W. Lysyl-protocollagen hydroxylase deficiency in fibroblasts from siblings with hydroxylysine-deficient collagen. Proc Natl Acad Sci U S A. 1972 Oct;69(10):2899–2903. doi: 10.1073/pnas.69.10.2899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miller R. L., Elsas L. J., Priest R. E. Ascorbate action on normal and mutant human lysyl hydroxylases from cultured dermal fibroblasts. J Invest Dermatol. 1979 May;72(5):241–247. doi: 10.1111/1523-1747.ep12531702. [DOI] [PubMed] [Google Scholar]
  14. Pasquali M., Dembure P. P., Still M. J., Elsas L. J. Urinary pyridinium cross-links: a noninvasive diagnostic test for Ehlers-Danlos syndrome type VI. N Engl J Med. 1994 Jul 14;331(2):132–133. doi: 10.1056/NEJM199407143310217. [DOI] [PubMed] [Google Scholar]
  15. Paterson C. R., Robins S. P., Horobin J. M., Preece P. E., Cuschieri A. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Br J Cancer. 1991 Nov;64(5):884–886. doi: 10.1038/bjc.1991.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pinnell S. R., Krane S. M., Kenzora J. E., Glimcher M. J. A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease. N Engl J Med. 1972 May 11;286(19):1013–1020. doi: 10.1056/NEJM197205112861901. [DOI] [PubMed] [Google Scholar]
  17. Robins S. P., Black D., Paterson C. R., Reid D. M., Duncan A., Seibel M. J. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest. 1991 Jun;21(3):310–315. doi: 10.1111/j.1365-2362.1991.tb01375.x. [DOI] [PubMed] [Google Scholar]
  18. Uebelhart D., Gineyts E., Chapuy M. C., Delmas P. D. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner. 1990 Jan;8(1):87–96. doi: 10.1016/0169-6009(91)90143-n. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES